Literature DB >> 3746634

Relationships among duration of infusion, dose, dosing interval, and steady-state plasma concentrations during intermittent intravenous infusions: studies with metronidazole.

D A Uccellini, D J Morgan, K Raymond.   

Abstract

Relationships among duration of infusion (T), dose, dosing interval (tau), maximum and minimum plasma drug concentrations at steady state (Cmax,ss and Cmin,ss, respectively), and the duration of effective plasma concentrations (tD) during multidose intermittent infusion regimens were studied by computer simulation using metronidazole as a model drug. Pharmacokinetic parameter values for metronidazole were obtained from the literature and the minimum effective plasma concentration (MEC) was taken as 6.0 micrograms/ml. Increasing the infusion period of the dose reduces Cmax,ss, but increases Cmin,ss. If intermittent bolus injection of a given dose of drug results in effective plasma concentrations for the entire dosage interval (i.e., Cmin,ss,bolus greater than MEC), then infusion of that dose over any period (T less than or equal to tau) will also result in effective concentrations for the entire dosage interval. However, if the dosage is such that Cmin,ss,bolus less than MEC, the relationships among duration of infusion, dose, dosage interval, and duration of effective plasma concentrations are complex. Therefore a nomogram was developed to allow selection of dose, dosing interval, and infusion period such that Cmax,ss and Cmin,ss could be maintained within a desired range.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3746634     DOI: 10.1007/bf01059286

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  5 in total

1.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli.

Authors:  A W Chow; V Patten; L B Guze
Journal:  J Infect Dis       Date:  1975-02       Impact factor: 5.226

3.  The effect of duration of intravenous infusion on maximum and threshold blood concentration for drugs exhibiting biexponential elimination kinetics.

Authors:  D J Morgan; K Raymond
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

4.  The effect of infusion time on the time course of drug concentration in blood.

Authors:  K Raymond; D J Morgan
Journal:  J Pharmacokinet Biopharm       Date:  1980-12

5.  High-dose metronidazole: pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer.

Authors:  H R Rabin; R C Urtasun; J Partington; D Koziol; M Sharon; K Walker
Journal:  Cancer Treat Rep       Date:  1980 Oct-Nov
  5 in total
  1 in total

1.  Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery.

Authors:  Ryan F Donnelly; Thakur Raghu Raj Singh; Martin J Garland; Katarzyna Migalska; Rita Majithiya; Cian M McCrudden; Prashant Laxman Kole; Tuan Mazlelaa Tuan Mahmood; Helen O McCarthy; A David Woolfson
Journal:  Adv Funct Mater       Date:  2012-07-09       Impact factor: 18.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.